Impact of methicillin-resistant staphylococcus aureus (MRSA) infection on patient outcome after pancreatoduodenectomy (PD): a cause for concern?

Keyphrases

• Patient Outcomes 100%
• Methicillin-resistant Staphylococcus Aureus Infection 100%
• Pancreaticoduodenectomy 100%
• Methicillin-resistant Staphylococcus Aureus 66%
• Drain Fluid 33%
• Postoperative Length of Stay 22%
• CA-MRSA 22%
• Skin Colonization 22%
• Chest Infection 22%
• Increased Incidence 11%
• Hospital Admission 11%
• Wound Infection 11%
• Hospital-acquired Infection 11%
• Postoperative Complications 11%
• Abdominal Drain 11%
• Blood Culture 11%
• Sputum 11%
• Postoperative Patients 11%
• Complication Outcome 11%
• Postpancreatectomy Hemorrhage 11%
• Postoperative Hemorrhage 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Methicillin Resistant Staphylococcus Aureus Infection 100%
• Methicillin-Resistant Staphylococcus Aureus 77%
• Chest Infection 22%
• Bleeding 11%
• Wound Infection 11%
• Hospital Infection 11%
• Postoperative Complication 11%
• Postoperative Hemorrhage 11%

Immunology and Microbiology

• Methicillin-Resistant Staphylococcus Aureus 100%
• Sputum 6%